The PD-1 ligands (PD-L1 or PD-L2) expression on the membrane of tumor cells or immune cells is a significant but not a definitive prediction indicator of the response to PD-1 blockade in some cancers [3–7]. This evidence concerns the gene CD274 and neoplasm.